X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

An agreement worth $2.5 million to settle a class action securities fraud suit was reached last week between Norcross, Ga.-based Immucor, a medical supply company specializing in blood testing and transfusion products, and attorneys representing stock purchasers alleging the firm’s officers issued misleading information concerning its financial health in 2004 and 2005.

A suit filed Aug. 31, 2005, said the company misled investors as to the impact of a criminal investigation of its Italian subsidiary and that unit’s president, Dr. Gioacchino De Chirico, who has since been named Immucor’s president.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.